Kudo, M. (2019). Objective Response by mRECIST Is an Independent Prognostic Factor of Overall Survival in Systemic Therapy for Hepatocellular Carcinoma. Liver Cancer.
Citación estilo ChicagoKudo, Masatoshi. "Objective Response By MRECIST Is an Independent Prognostic Factor of Overall Survival in Systemic Therapy for Hepatocellular Carcinoma." Liver Cancer 2019.
Cita MLAKudo, Masatoshi. "Objective Response By MRECIST Is an Independent Prognostic Factor of Overall Survival in Systemic Therapy for Hepatocellular Carcinoma." Liver Cancer 2019.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.